TRT Monitoring: Essential Blood Tests

Testosterone replacement therapy (TRT) can be transformative for men with clinically low testosterone. It can restore energy, improve mood, support muscle mass, and revive libido. However, TRT is not a set-and-forget treatment. Regular blood monitoring is essential to ensure the therapy is working correctly, to catch potential side effects early, and to keep your overall health in check. Simply tracking testosterone alone is not enough — a comprehensive monitoring approach is what separates safe, effective TRT from a risky guessing game. For the basics first, see our guide to testosterone.

Why TRT Monitoring Matters

When you introduce exogenous testosterone into your body, it affects far more than just your testosterone levels. TRT influences your entire hormonal axis, your blood composition, your liver, your prostate, and your cardiovascular system. Without regular monitoring, problems can develop silently:

• Testosterone levels may be too high or too low for your protocol, leading to continued symptoms or unnecessary side effects
• Estradiol can rise as testosterone is converted through aromatisation, causing water retention, mood disturbances, and gynecomastia
• Red blood cell production can increase excessively, raising the risk of blood clots
• Liver and kidney function should be tracked to ensure organs are handling the therapy well
• Prostate health needs monitoring, as testosterone can stimulate prostate tissue

Regular blood work transforms TRT from a blunt instrument into a precisely managed therapy.

Key Markers to Track

Testosterone (Total and Free)

This is the foundation of TRT monitoring. Your doctor will use these values to assess whether your dose is achieving the target range:

• Total testosterone: Most clinicians aim for levels in the mid-to-upper normal range (15-30 nmol/L or 500-850 ng/dL), depending on your symptoms and protocol
• Free testosterone: Provides a clearer picture of biologically active hormone, especially if SHBG is elevated
• Timing matters: For injectable testosterone, blood should typically be drawn at the trough (just before the next injection) to assess your lowest levels. For daily gels or creams, draw blood 2-4 hours after application

Estradiol (E2)

Testosterone is partially converted to estradiol by the enzyme aromatase. On TRT, estradiol levels can rise significantly:

• Optimal range on TRT: Generally 70-150 pmol/L (20-40 pg/mL), though this is individual
• High estradiol symptoms: Water retention, bloating, mood swings, tender or swollen breast tissue (gynecomastia), and reduced libido
• Low estradiol symptoms: Joint pain, dry skin, low mood, and decreased libido — overly aggressive aromatase inhibitor use can crash estradiol, which carries its own risks

Estradiol should be in balance with testosterone. The ratio between the two hormones is as important as the individual numbers.

PSA (Prostate-Specific Antigen)

PSA is a protein produced by the prostate gland. Testosterone can stimulate prostate tissue, so monitoring PSA is a standard part of TRT safety:

• Baseline PSA should be measured before starting TRT
• A significant rise in PSA (typically >1.4 ng/mL increase within 12 months, or a PSA above 4.0 ng/mL) warrants further investigation by a urologist
• PSA monitoring does not replace regular prostate health assessments

Liver Enzymes (ALT, AST, GGT)

While injectable and transdermal testosterone have minimal direct liver impact compared to oral forms, monitoring liver function remains important:

• ALT and AST: Elevated levels may indicate liver stress, which can be caused by concurrent medications, supplements, or underlying conditions
• GGT: Sensitive to alcohol use and certain medications

Baseline measurement and periodic checks ensure your liver is functioning well throughout therapy.

Complete Blood Count (CBC) — Especially Hematocrit and Hemoglobin

This is one of the most critical monitoring tests on TRT. Testosterone stimulates erythropoiesis (red blood cell production), which can cause a condition called polycythemia — an excessive increase in red blood cells:

• Hematocrit: Measures the percentage of blood volume occupied by red blood cells. On TRT, hematocrit above 52-54% is a concern. Very high hematocrit increases blood viscosity and raises the risk of stroke, heart attack, and deep vein thrombosis
• Hemoglobin: Should be monitored alongside hematocrit. Levels consistently above 18.5 g/dL warrant attention

If hematocrit rises too high, your doctor may adjust your dose, change the delivery method, or recommend therapeutic blood donation to reduce red blood cell volume.

Prolactin

Prolactin is a hormone produced by the pituitary gland. It is not directly affected by TRT in most cases, but monitoring is recommended because:

• Elevated prolactin can cause low libido, erectile dysfunction, and fatigue — symptoms that overlap with low testosterone
• Persistently high prolactin may indicate a pituitary adenoma (prolactinoma), which requires separate treatment
• Some men on TRT who do not respond as expected may have an underlying prolactin issue

LH and FSH

Luteinising hormone (LH) and follicle-stimulating hormone (FSH) are pituitary hormones that signal the testes to produce testosterone and sperm. On TRT, these hormones are expected to be suppressed because the exogenous testosterone provides negative feedback to the pituitary:

• Expected on TRT: Low or undetectable LH and FSH
• This suppression means the testes are not being stimulated, which leads to testicular atrophy and significantly reduced or absent sperm production
• Men who want to preserve fertility while on TRT should discuss the use of hCG (human chorionic gonadotropin) with their doctor

How Often to Test

The recommended testing schedule depends on where you are in your TRT journey:

Before Starting TRT (Baseline)

A comprehensive baseline panel should include all of the above markers, plus a general health check. This establishes your starting point and helps your doctor identify any pre-existing conditions.

6-8 Weeks After Starting or Adjusting Dose

This is when blood levels stabilise on a new protocol. Testing at this point confirms whether the dose is correct and identifies early side effects.

Every 3-6 Months During the First Year

Frequent monitoring during the first year helps fine-tune the protocol and catch emerging issues like rising hematocrit or estradiol imbalance.

Every 6-12 Months Once Stable

Once your protocol is dialled in and markers are consistently within range, biannual testing is usually sufficient. However, any new symptoms should prompt additional testing.

Red Flags to Watch For

Between blood tests, be alert for symptoms that may indicate a problem:

• Severe headaches, visual changes, or dizziness: Could indicate high hematocrit or blood pressure issues
• Swelling in legs or shortness of breath: May suggest cardiovascular complications
• Breast tenderness or swelling: Indicates elevated estradiol
• Urinary changes: Difficulty urinating, frequent urination, or weak stream — may be prostate-related
• Mood instability or worsening symptoms: Could mean the dose needs adjustment

Comprehensive Monitoring vs Just Testosterone

The biggest mistake men on TRT make is only checking testosterone levels. A testosterone number in range means nothing if your hematocrit is dangerously high, your estradiol is out of balance, or your PSA is rising. Comprehensive monitoring protects your health and ensures you get the full benefit of therapy with the lowest possible risk.

TRT is a medical treatment that requires medical oversight. Regular blood work is not optional — it is the foundation of safe, effective testosterone replacement.